176 related articles for article (PubMed ID: 23111469)
1. Plasminogen activator inhibitor-1 (PAI-1) expression in relation to hypoxia and oncoproteins in clinical cervical tumors.
Lara PC; Lloret M; Valenciano A; Clavo B; Pinar B; Rey A; Henríquez-Hernández LA
Strahlenther Onkol; 2012 Dec; 188(12):1139-45. PubMed ID: 23111469
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia downregulates Ku70/80 expression in cervical carcinoma tumors.
Lara PC; Lloret M; Clavo B; Apolinario RM; Bordón E; Rey A; Falcón O; Alonso AR; Belka C
Radiother Oncol; 2008 Nov; 89(2):222-6. PubMed ID: 18706726
[TBL] [Abstract][Full Text] [Related]
3. Major vault protein may affect nonhomologous end-joining repair and apoptosis through Ku70/80 and bax downregulation in cervical carcinoma tumors.
Lloret M; Lara PC; Bordón E; Fontes F; Rey A; Pinar B; Falcón O
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):976-9. PubMed ID: 19251084
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas.
Skomedal H; Kristensen GB; Lie AK; Holm R
Gynecol Oncol; 1999 May; 73(2):223-8. PubMed ID: 10329038
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
Hazelbag S; Kenter GG; Gorter A; Fleuren GJ
Int J Cancer; 2004 Dec; 112(6):1020-8. PubMed ID: 15386352
[TBL] [Abstract][Full Text] [Related]
6. p16, p14, p53, and cyclin D1 expression and HPV analysis in small cell carcinomas of the uterine cervix.
Horn LC; Lindner K; Szepankiewicz G; Edelmann J; Hentschel B; Tannapfel A; Bilek K; Liebert UG; Richter CE; Einenkel J; Leo C
Int J Gynecol Pathol; 2006 Apr; 25(2):182-6. PubMed ID: 16633070
[TBL] [Abstract][Full Text] [Related]
7. Severe hypoxia induces chemo-resistance in clinical cervical tumors through MVP over-expression.
Lara PC; Lloret M; Clavo B; Apolinario RM; Henríquez-Hernández LA; Bordón E; Fontes F; Rey A
Radiat Oncol; 2009 Aug; 4():29. PubMed ID: 19660100
[TBL] [Abstract][Full Text] [Related]
8. Tumor hypoxia, p53, and prognosis in cervical cancers.
Haensgen G; Krause U; Becker A; Stadler P; Lautenschlaeger C; Wohlrab W; Rath FW; Molls M; Dunst J
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):865-72. PubMed ID: 11429213
[TBL] [Abstract][Full Text] [Related]
9. Down-expression pattern of Ku70 and p53 coexisted in colorectal cancer.
Lu Y; Gao J; Lu Y
Med Oncol; 2015 Apr; 32(4):98. PubMed ID: 25731619
[TBL] [Abstract][Full Text] [Related]
10. A novel Ku70 function in colorectal homeostasis separate from nonhomologous end joining.
Puebla-Osorio N; Kim J; Ojeda S; Zhang H; Tavana O; Li S; Wang Y; Ma Q; Schluns KS; Zhu C
Oncogene; 2014 May; 33(21):2748-57. PubMed ID: 23752193
[TBL] [Abstract][Full Text] [Related]
11. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
Bilyk OO; Pande NT; Buchynska LG
Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468
[TBL] [Abstract][Full Text] [Related]
12. miR-202 inhibits the progression of human cervical cancer through inhibition of cyclin D1.
Yi Y; Li H; Lv Q; Wu K; Zhang W; Zhang J; Zhu D; Liu Q; Zhang W
Oncotarget; 2016 Nov; 7(44):72067-72075. PubMed ID: 27732565
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis.
Suzuki Y; Nakano T; Kato S; Ohno T; Tsujii H; Oka K
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):231-6. PubMed ID: 15337561
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of cyclin D1, p16Ink4a, p21WAF1, and Ki-67 correlates with the severity of cervical neoplasia.
Portari EA; Russomano FB; de Camargo MJ; Machado Gayer CR; da Rocha Guillobel HC; Santos-Rebouças CB; Brito Macedo JM
Int J Gynecol Pathol; 2013 Sep; 32(5):501-8. PubMed ID: 23896712
[TBL] [Abstract][Full Text] [Related]
15. Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-κB-dependent cyclin D1 signaling.
Kuo SH; Chou CH; Cheng AL; Wang CW; Chen YH; Chen RJ
Gynecol Oncol; 2012 Aug; 126(2):245-51. PubMed ID: 22564715
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 gene expression in human cervical neoplasia.
Nichols GE; Williams ME; Gaffey MJ; Stoler MH
Mod Pathol; 1996 Apr; 9(4):418-25. PubMed ID: 8729983
[TBL] [Abstract][Full Text] [Related]
17. Regulation of plasminogen activator inhibitor-1 expression by tumor suppressor protein p53.
Shetty S; Shetty P; Idell S; Velusamy T; Bhandary YP; Shetty RS
J Biol Chem; 2008 Jul; 283(28):19570-80. PubMed ID: 18469003
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 expression in oral squamous cell carcinomas: clinicopathological relevance and correlation with p53 expression.
Lam KY; Ng IO; Yuen AP; Kwong DL; Wei W
J Oral Pathol Med; 2000 Apr; 29(4):167-72. PubMed ID: 10766394
[TBL] [Abstract][Full Text] [Related]
19. Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix.
Cheung TH; Yu MM; Lo KW; Yim SF; Chung TK; Wong YF
Cancer Lett; 2001 May; 166(2):199-206. PubMed ID: 11311493
[TBL] [Abstract][Full Text] [Related]
20. Metformin Modulates Cyclin D1 and P53 Expression to Inhibit Cell Proliferation and to Induce Apoptosis in Cervical Cancer Cell Lines.
Yudhani RD; Astuti I; Mustofa M; Indarto D; Muthmainah M
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1667-1673. PubMed ID: 31244286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
